Citations (145)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Elias Bekka & Florian Eyer. (2022) Dose-related hypoglycemia in venlafaxine poisoning: a retrospective cohort study. Clinical Toxicology 60:12, pages 1336-1344.
Read now
Read now
Konstantin A. Demin, Maxim Sysoev, Maria V. Chernysh, Anna K. Savva, Mamiko Koshiba, Edina A. Wappler-Guzzetta, Cai Song, Murilo S. De Abreu, Brian Leonard, Matthew O. Parker, Brian H. Harvey, Li Tian, Eero Vasar, Tatyana Strekalova, Tamara G. Amstislavskaya, Andrey D. Volgin, Erik T. Alpyshov, Dongmei Wang & Allan V. Kalueff. (2019) Animal models of major depressive disorder and the implications for drug discovery and development. Expert Opinion on Drug Discovery 14:4, pages 365-378.
Read now
Read now
Feng Li, Zhao-li Ling, Zhong-jian Wang, Ze-yu Zhong, Nan Shu, Mian Zhang, Can Liu, Li Liu & Xiao-dong Liu. (2017) Differential effects of pravastatin on the pharmacokinetics of paroxetine in normal and diabetic rats. Xenobiotica 47:1, pages 20-30.
Read now
Read now
Marie-Catherine Francino, Marie Bretaudeau Deguigne, Julie Badin, Alain Turcant & Dominique Perrotin. (2012) Hypoglycaemia: A little known effect of Venlafaxine overdose. Clinical Toxicology 50:3, pages 215-217.
Read now
Read now
Michelle J Ormseth, Beth A Scholz & Chad S Boomershine. (2011) Duloxetine in the management of diabetic peripheral neuropathic pain. Patient Preference and Adherence 5, pages 343-356.
Read now
Read now
Istvan Bitter, Dora Filipovits & Pal Czobor. (2011) Adverse reactions to duloxetine in depression. Expert Opinion on Drug Safety 10:6, pages 839-850.
Read now
Read now
Antonio Crucitti, Qi Zhang, Mary Nilsson, Stephan Brecht, Charles R. Yang & Joachim Wernicke. (2010) Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis. Current Medical Research and Opinion 26:11, pages 2579-2588.
Read now
Read now
Norbert Müller, Rebecca Schennach, Michael Riedel & Hans-Jürgen Möller. (2008) Duloxetine in the treatment of major psychiatric and neuropathic disorders. Expert Review of Neurotherapeutics 8:4, pages 527-536.
Read now
Read now
Yves Lecrubier, Michael Bauer, Robert Hirschfeld, Susan Mcelroy & Trisha Suppes. (2008) Awareness of the metabolic syndrome in patients with bipolar disorder: A comparison of US and European psychiatrists. International Journal of Psychiatry in Clinical Practice 12:3, pages 187-195.
Read now
Read now
Roger S McIntyre, Joanna K Soczynska, Jakub Z Konarski & Sidney H Kennedy. (2006) The effect of antidepressants on lipid homeostasis: a cardiac safety concern?. Expert Opinion on Drug Safety 5:4, pages 523-537.
Read now
Read now
Roger S McIntyre, Joanna K Soczynska, Gary F Lewis, Glenda M MacQueen, Jakub Z Konarski & Sidney H Kennedy. (2006) Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities. Expert Opinion on Pharmacotherapy 7:10, pages 1305-1321.
Read now
Read now
Articles from other publishers (134)
Lisa Radosta. (2024) Behavior Changes Associated with Metabolic Disease of Dogs and Cats. Veterinary Clinics of North America: Small Animal Practice 54:1, pages 17-28.
Crossref
Crossref
Min Hu, Jia-ying Cai, Yao He, Kui Chen, Feng Hao, Jin-sen Kang, Yan Pan, Lu Tie & Xue-jun Li. (2023) Protective effects of curcumin on desipramine-induced islet β-cell damage via AKAP150/PKA/PP2B complex. Acta Pharmacologica Sinica.
Crossref
Crossref
N Simple Santi, Sashi B Biswal, Birendra Narayan Naik, Jyoti Prakash Sahoo & Bhabagrahi Rath. (2023) Metabolic Effects of Antidepressants: Results of a Randomized Study’s Interim Analysis. Cureus.
Crossref
Crossref
André J. Scheen. (2023) Metabolic disorders induced by psychotropic drugs. Annales d'Endocrinologie 84:3, pages 357-363.
Crossref
Crossref
Maria Carmen Iglesias-Osma, Maria José García-Barrado, David Hernandez-Gonzalez, Kévin Perrier, Pénélope Viana & Christian Carpéné. (2023) The anxiolytic drug opipramol inhibits insulin-induced lipogenesis in fat cells and insulin secretion in pancreatic islets. Journal of Physiology and Biochemistry 79:2, pages 415-425.
Crossref
Crossref
Houman Rashidian, Mehala Subramaniapillai, Caroline Park, Orly Lipsitz, Hannah Zuckerman, Bing Cao, Yena Lee, Hartej Gill, Roger Nelson Rodrigues, Joshua D. Di Vincenzo, Michelle Iacobucci, Saja Jaberi, Joshua D. Rosenblat, Roger S. McIntyre & Rodrigo B. Mansur. (2022) Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder. Journal of Psychopharmacology 37:3, pages 313-317.
Crossref
Crossref
Patricio Molero, Gabriel Reina, Jan Dirk Blom, Miguel Ángel Martínez-González, Aischa Reinken, E. Ronald de Kloet & Marc L. Molendijk. (2023) COVID-19 risk, course and outcome in people with mental disorders: a systematic review and meta-analyses. Epidemiology and Psychiatric Sciences 32.
Crossref
Crossref
Gerhard Heinze-Martin, Diana Patricia Guizar & Napoleon Andrés Bernard. 2023. The Diabetes Textbook. The Diabetes Textbook
487
498
.
Yue He, Li Tong, Feng Guo, Saisai Zhao, Jianli Zhang, Xuecan Guo, Yuchun Tao, Xinli Lin & Lina Jin. (2022) Depression status and insulin resistance in adults with obesity: A cross-sectional study. Journal of Psychosomatic Research 163, pages 111049.
Crossref
Crossref
Laura F. Berto, Claudia K. Suemoto, Arlinda B. Moreno, Maria de Jesus M. Fonseca, Maria Angélica A. Nunes, Maria del Carmen B. Molina, Sandhi M. Barreto, Maria de Fátima Haueisen Sander Diniz, Paulo A. Lotufo, Isabela M. Benseñor & Andre R. Brunoni. (2022) Increased Prevalence of Depression and Anxiety Among Subjects With Metabolic Syndrome in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Journal of the Academy of Consultation-Liaison Psychiatry 63:6, pages 529-538.
Crossref
Crossref
Maša Čater & Sabine M. Hölter. (2022) A Pathophysiological Intersection of Diabetes and Alzheimer’s Disease. International Journal of Molecular Sciences 23:19, pages 11562.
Crossref
Crossref
Stacie L. Ong, Fahim Abbasi, Kathleen Watson, Thalia Robakis, Alison Myoraku & Natalie Rasgon. (2022) Family history of diabetes moderates metabolic depression endophenotypes in overweight/obese adults. Journal of Psychiatric Research 151, pages 583-589.
Crossref
Crossref
Salma Habib, Sai Lahari Sangaraju, Daniela Yepez, Xavier A Grandes & Ramya Talanki Manjunatha. (2022) The Nexus Between Diabetes and Depression: A Narrative Review. Cureus.
Crossref
Crossref
Wenqiang Chen, Weikang Cai, Benjamin Hoover & C. Ronald Kahn. (2022) Insulin action in the brain: cell types, circuits, and diseases. Trends in Neurosciences 45:5, pages 384-400.
Crossref
Crossref
Christopher Rohde, Reimar W. Thomsen & Søren D. Østergaard. (2022) A Within-Subject Before-After Study of the Impact of Antidepressants on Hemoglobin A1c and Low-Density Lipoprotein Levels in Type 2 Diabetes. Journal of Clinical Psychopharmacology 42:2, pages 125-132.
Crossref
Crossref
Hans-Peter KapfhammerHans-Peter Kapfhammer. 2022. Depression, Angst, traumatischer Stress und internistische Erkrankungen. Depression, Angst, traumatischer Stress und internistische Erkrankungen
221
287
.
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry
305
450
.
Hon-Cheong So, Carlos Kwan-long Chau, Yu-ying Cheng & Pak C. Sham. (2020) Causal relationships between blood lipids and depression phenotypes: a Mendelian randomisation analysis. Psychological Medicine 51:14, pages 2357-2369.
Crossref
Crossref
Sameer Khasbage, Ravindra Shukla, Praveen Sharma & Surjit Singh. (2021) A randomized control trial of duloxetine and gabapentin in painful diabetic neuropathy. Journal of Diabetes 13:7, pages 532-541.
Crossref
Crossref
Tim L. Emmerzaal, Leah Jacobs, Bram Geenen, Vivienne Verweij, Eva Morava, Richard J. Rodenburg & Tamas Kozicz. (2020) Chronic fluoxetine or ketamine treatment differentially affects brain energy homeostasis which is not exacerbated in mice with trait suboptimal mitochondrial function. European Journal of Neuroscience 53:9, pages 2986-3001.
Crossref
Crossref
Hugo Martin, Sébastien Bullich, Bruno P. Guiard & Xavier Fioramonti. (2021) The impact of insulin on the serotonergic system and consequences on diabetes‐associated mood disorders. Journal of Neuroendocrinology 33:4.
Crossref
Crossref
Houman Rashidian, Mehala Subramaniapillai, Caroline Park, Orly Lipsitz, Hannah Zuckerman, Kayla Teopiz, Bing Cao, Yena Lee, Hartej Gill, Roger Ho, Kangguang Lin, Nelson B. Rodrigues, Michelle Iacobucci, Joshua D. Rosenblat, Roger S. McIntyre & Rodrigo B. Mansur. (2021) Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder. Journal of Affective Disorders 282, pages 448-453.
Crossref
Crossref
Alix Kloster, Molly M. Hyer, Samya Dyer, Charlie Salome-Sanchez & Gretchen N. Neigh. (2021) High Fructose Diet Induces Sex-specific Modifications in Synaptic Respiration and Affective-like Behaviors in Rats. Neuroscience 454, pages 40-50.
Crossref
Crossref
Andrea Murru, Gerard Anmella, Anna Giménez & Eduard Vieta. 2021. Neurobiology of Bipolar Disorder. Neurobiology of Bipolar Disorder
257
274
.
Jenny W. Sun, Sonia Hernández-Díaz, Sebastien Haneuse, Florence T. Bourgeois, Seanna M. Vine, Mark Olfson, Brian T. Bateman & Krista F. Huybrechts. (2021) Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents. JAMA Psychiatry 78:1, pages 91.
Crossref
Crossref
Hsin-Ya Kuo, Hsiu-Min Chen, Ching-Chih Lee, Hsuan-Han Lee, Chuan-Jung Kuo, Chun-Sheng Hsu, Chih-Chuan Pan, Ning Su & Che-Sheng Chu. (2020) Antidepressants and Risk of Type 2 Diabetes Mellitus. Journal of Clinical Psychopharmacology 40:4, pages 359-365.
Crossref
Crossref
Andrea D. Mekonnen, Aubrey A. Mills, Andrea L. Wilhite & Theresa K. Hoffman. (2020) Desvenlafaxine-associated hyperglycemia: A case report and literature review. Mental Health Clinician 10:3, pages 85-89.
Crossref
Crossref
Huan Yu, Hui Li, Xiaoqian Liu, Xiaoli Du & Binbin Deng. (2020) Levels of serum S100B are associated with cognitive dysfunction in patients with type 2 diabetes. Aging 12:5, pages 4193-4203.
Crossref
Crossref
Ajit Kumar Thakur, Sakshi Tyagi & Nikhila Shekhar. (2019) Comorbid brain disorders associated with diabetes: therapeutic potentials of prebiotics, probiotics and herbal drugs. Translational Medicine Communications 4:1.
Crossref
Crossref
Josep Mercader, Agustín G. Sabater, Sophie Le Gonidec, Pauline Decaunes, Alice Chaplin, Saioa Gómez-Zorita, Fermín I. Milagro & Christian Carpéné. (2019) Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet. Journal of Pharmacology and Experimental Therapeutics 371:2, pages 555-566.
Crossref
Crossref
Senthil Kumaran Satyanarayanan, Yin-Hwa Shih, Yeong-Ray Wen, Mahalakshmi Palani, Yi-Wen Lin, Huanxing Su, Piotr Gałecki & Kuan-Pin Su. (2019) miR-200a-3p modulates gene expression in comorbid pain and depression: Molecular implication for central sensitization. Brain, Behavior, and Immunity 82, pages 230-238.
Crossref
Crossref
Weibin Zha, Tao Hu, Mary F. Hebert & Joanne Wang. (2019) Effect of Pregnancy on Paroxetine-Induced Adiposity and Glucose Intolerance in Mice. Journal of Pharmacology and Experimental Therapeutics 371:1, pages 113-120.
Crossref
Crossref
Johann Steiner, Brisa S. Fernandes, Paul C. Guest, Henrik Dobrowolny, Gabriela Meyer-Lotz, Sabine Westphal, Katrin Borucki, Kolja Schiltz, Zoltán Sarnyai & Hans-Gert Bernstein. (2018) Glucose homeostasis in major depression and schizophrenia: a comparison among drug-naïve first-episode patients. European Archives of Psychiatry and Clinical Neuroscience 269:4, pages 373-377.
Crossref
Crossref
Ching-En Lin, Chi-Hsiang Chung, Li-Fen Chen, Ching-Hui You, Wu-Chien Chien & Po-Han Chou. (2019) Risk of incident hypertension, diabetes, and dyslipidemia after first posttraumatic stress disorder diagnosis: A nationwide cohort study in Taiwan. General Hospital Psychiatry 58, pages 59-66.
Crossref
Crossref
JonathanW Birdsall, SamanthaL Schmitz, OluchiJ Abosi, LyndseyE DuBose, GaryL Pierce & JessG Fiedorowicz. (2019) Inflammatory and vascular correlates of mood change over 8 weeks. Heart and Mind 3:2, pages 47.
Crossref
Crossref
Aline Isabel da Silva, Glauber Rudá F. Braz, Severina Cássia de A. Silva, Anderson Apolonio da S. Pedroza, Nelson Correia de Lima-Júnior, Tércya Lúcidi de A. Silva & Claudia Jacques Lagranha. (2019) Body composition, biochemical, behavioral and molecular alterations in overfed rats after chronic exposure to SSRI. Behavioural Brain Research 356, pages 62-70.
Crossref
Crossref
I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, R. M. Faizullin & K. E. Pryakhina. (2018) Anxiolytic and Antidepressant Actions of Emoxypine, Reamberin, and Mexidol in Experimental Diabetes Mellitus. Neuroscience and Behavioral Physiology 49:1, pages 136-141.
Crossref
Crossref
Gerhard Heinze, Diana Guizar-Sánchez & Napoleón Bernard-Fuentes. 2019. The Diabetes Textbook. The Diabetes Textbook
417
428
.
Thi Thu Ha Nguyen, Anne Roussin, Vanessa Rousseau, Jean-Louis Montastruc & François Montastruc. (2018) Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological–Pharmacodynamic Study in VigiBase®. Drug Safety 41:11, pages 1087-1096.
Crossref
Crossref
Oluchi Abosi, Sneha Lopes, Samantha Schmitz & Jess G. Fiedorowicz. (2018) Cardiometabolic effects of psychotropic medications. Hormone Molecular Biology and Clinical Investigation 36:1.
Crossref
Crossref
Elizabeth J. Mayer-Davis, Anna R. Kahkoska, Craig Jefferies, Dana Dabelea, Naby Balde, Chun X. Gong, Pablo Aschner & Maria E. Craig. (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatric Diabetes 19, pages 7-19.
Crossref
Crossref
Christian Carpéné, Saioa Gómez-Zorita, Alice Chaplin & Josep Mercader. (2018) Metabolic Effects of Oral Phenelzine Treatment on High-Sucrose-Drinking Mice. International Journal of Molecular Sciences 19:10, pages 2904.
Crossref
Crossref
Eleni A. Greenwood, Lauri A. Pasch, Marcelle I. Cedars, Richard S. Legro & Heather G. Huddleston. (2018) Association among depression, symptom experience, and quality of life in polycystic ovary syndrome. American Journal of Obstetrics and Gynecology 219:3, pages 279.e1-279.e7.
Crossref
Crossref
Justin Gagnon, Marie-Thérèse Lussier, Brenda MacGibbon, Stella S. Daskalopoulou & Gillian Bartlett. (2018) The Impact of Antidepressant Therapy on Glycemic Control in Canadian Primary Care Patients With Diabetes Mellitus. Frontiers in Nutrition 5.
Crossref
Crossref
Christian Carpéné, Josep Mercader, Sophie Le Gonidec, Stéphane Schaak, Jeanne Mialet-Perez, Alexia Zakaroff-Girard & Jean Galitzky. (2018) Body fat reduction without cardiovascular changes in mice after oral treatment with the MAO inhibitor phenelzine. British Journal of Pharmacology 175:12, pages 2428-2440.
Crossref
Crossref
Makbule Gezmen-Karadağ, Elif Çelik, Fatma Zehra Kadayifçi, Özge Yeşildemir, Yasemin Ertaş Öztürk & Duygu Ağagündüz. (2018) Role of food-drug interactions in neurological and psychological diseases. Acta Neurobiologiae Experimentalis 78:3, pages 187-197.
Crossref
Crossref
Alexandra K. Lee, Clare J. Lee, Elbert S. Huang, A. Richey Sharrett, Josef Coresh & Elizabeth Selvin. (2017) Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 40:12, pages 1661-1667.
Crossref
Crossref
Kiyuri Naicker, Simon Øverland, Jeffrey A. Johnson, Douglas Manuel, Jens C. Skogen, Børge Sivertsen & Ian Colman. (2017) Symptoms of anxiety and depression in type 2 diabetes: Associations with clinical diabetes measures and self-management outcomes in the Norwegian HUNT study. Psychoneuroendocrinology 84, pages 116-123.
Crossref
Crossref
Yen-Hao Tran, Catharina C. M. Schuiling-Veninga, Jorieke E. H. Bergman, Henk Groen & Bob Wilffert. (2017) Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study. CNS Drugs 31:6, pages 483-493.
Crossref
Crossref
T. Wohland, J.D. Holstein, O.M. Patzer, M. Mende, T. Tiemann, C. Koch-Tessarek, P. Kovacs & A. Holstein. (2017) New risk and protective factors for severe hypoglycaemia in people with type 1 diabetes. Nutrition, Metabolism and Cardiovascular Diseases 27:5, pages 407-414.
Crossref
Crossref
I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, R. M. Faizullin & K. E. Pryakhina. (2017) Anxiolytic and antidepressant effects of emoxipine, reamberin and mexidol in experimental diabetes mellitus. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117:5, pages 52.
Crossref
Crossref
Glenda MacQueen, Pasqualina Santaguida, Homa Keshavarz, Natalia Jaworska, Mitchell Levine, Joseph Beyene & Parminder Raina. (2016) Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults. The Canadian Journal of Psychiatry 62:1, pages 11-23.
Crossref
Crossref
Hans-Peter Kapfhammer. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
2693
2805
.
Taliha H. Aydın, Özgür D. Can, Ümide Demir Özkay & Nazlı Turan. (2016) Effect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanisms. Fundamental & Clinical Pharmacology 30:6, pages 549-567.
Crossref
Crossref
Jamie Kammer, Akiko S. Hosler, Emily Leckman-Westin & A. Gregory DiRienzo. (2016) Use of antidepressant medications not associated with A1C among individuals with diabetes in NHANES sample. Primary Care Diabetes 10:5, pages 360-368.
Crossref
Crossref
Thibault Viard, Cecilia Destephen, Meissa Kare & Magali Labadie. (2016) Intoxication à l’escitalopram et à la venlafaxine compliquée d’hypoglycémies récidivantes. Toxicologie Analytique et Clinique 28:3, pages 224-227.
Crossref
Crossref
Riin Reimets, Sirli Raud, Maarja Loomets, Tanel Visnapuu, Vallo Volke, Ain Reimets, Mario Plaas & Eero Vasar. (2016) Variability in the effect of antidepressants upon Wfs1-deficient mice is dependent on the drugs’ mechanism of actions. Behavioural Brain Research 308, pages 53-63.
Crossref
Crossref
I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, R. M. Faizullin, K. E. Pryakhina & A. V. Kalugina. (2016) Anxiolytic and Antidepressant Actions of 3-Hydroxypyridine and Succinic Acid Derivatives in Alloxan Diabetes. Neuroscience and Behavioral Physiology 46:6, pages 620-625.
Crossref
Crossref
Krista Minéia Wartchow, Ana Carolina Tramontina, Daniela F. de Souza, Regina Biasibetti, Larissa D. Bobermin & Carlos-Alberto Gonçalves. (2016) Insulin Stimulates S100B Secretion and These Proteins Antagonistically Modulate Brain Glucose Metabolism. Neurochemical Research 41:6, pages 1420-1429.
Crossref
Crossref
Davy Vancampfort, Simon Rosenbaum, Philip B. Ward, Zachary Steel, Oscar Lederman, Alice Veronica Lamwaka, Justin W. Richards & Brendon Stubbs. (2016) Type 2 Diabetes Among People With Posttraumatic Stress Disorder. Psychosomatic Medicine 78:4, pages 465-473.
Crossref
Crossref
Davy Vancampfort, Alex J. Mitchell, Marc De Hert, Pascal Sienaert, Michel Probst, Roselien Buys & Brendon Stubbs. (2015) TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META-ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS. Depression and Anxiety 32:10, pages 763-773.
Crossref
Crossref
Imre Annamária, Kolcsár Melinda, Groşan Alexandra, M Imre & Dogaru Maria Titica. (2015) Metabolic Effects of Two Different Doses of Venlafaxine Therapy on Rats. Acta Medica Marisiensis 61:3, pages 196-199.
Crossref
Crossref
Katherine Semenkovich, Miriam E. Brown, Dragan M. Svrakic & Patrick J. Lustman. (2015) Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment. Drugs 75:6, pages 577-587.
Crossref
Crossref
Varsha G. Vimalananda & Edward A. Ruiz-Narváez. (2015) Response to Comment on Vimalananda et al. Depressive Symptoms, Antidepressant Use, and the Incidence of Diabetes in the Black Women’s Health Study. Diabetes Care 2014;37:2211–2217. Diabetes Care 38:2, pages e24-e24.
Crossref
Crossref
H.-P. Kapfhammer. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
114
.
Irvin Epstein, Isaac Szpindel & Martin A. Katzman. (2014) Pharmacological approaches to manage persistent symptoms of major depressive disorder: rationale and therapeutic strategies. Psychiatry Research 220, pages S15-S33.
Crossref
Crossref
C. Carpéné, S. Gomez-Zorita, R. Gupta, S. Grès, C. Rancoule, T. Cadoudal, J. Mercader, A. Gomez, C. Bertrand & Z. Iffiu-Soltész. (2014) Combination of low dose of the anti-adipogenic agents resveratrol and phenelzine in drinking water is not sufficient to prevent obesity in very-high-fat diet-fed mice. European Journal of Nutrition 53:8, pages 1625-1635.
Crossref
Crossref
R. Torrents, R. Brun, C. Schmitt, A. Boulamery, N. Simon & L. de Haro. (2014) Hypoglycémie et surdosage volontaire en inhibiteurs sélectifs de la recapture de la sérotonine (citalopram et venlafaxine)Hypoglycemia and voluntary overdose of selective serotonin reuptake inhibitors (citalopram and venlafaxine). Annales françaises de médecine d'urgence 4:5, pages 332-333.
Crossref
Crossref
Varsha G. Vimalananda, Julie R. Palmer, Hanna Gerlovin, Lauren A. Wise, James L. Rosenzweig, Lynn Rosenberg & Edward A. Ruiz-Narváez. (2014) Depressive Symptoms, Antidepressant Use, and the Incidence of Diabetes in the Black Women’s Health Study. Diabetes Care 37:8, pages 2211-2217.
Crossref
Crossref
D. Vancampfort, C. U. Correll, M. Wampers, P. Sienaert, A. J. Mitchell, A. De Herdt, M. Probst, T. W. Scheewe & M. De Hert. (2013) Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables. Psychological Medicine 44:10, pages 2017-2028.
Crossref
Crossref
Alexander Bystritsky, Jessica Danial & David Kronemyer. (2014) Interactions Between Diabetes and Anxiety and Depression. Endocrinology and Metabolism Clinics of North America 43:1, pages 269-283.
Crossref
Crossref
Line Iden Berge, Trond Riise, Øivind Hundal, Ketil Joachim Ødegaard, Steven Dilsaver & Anders Lund. (2013) Prevalence and characteristics of depressive disorders in type 1 diabetes. BMC Research Notes 6:1.
Crossref
Crossref
Katharine BarnardRobert C. PevelerRichard I.G. Holt. (2013) Antidepressant Medication as a Risk Factor for Type 2 Diabetes and Impaired Glucose Regulation. Diabetes Care 36:10, pages 3337-3345.
Crossref
Crossref
David A. Brott, Melody Diamond, Pam Campbell, Andy Zuvich, Letitia Cheatham, Patricia Bentley, Mary Ann Gorko, James Fikes & JoAnne Saye. (2013) An acute rat in vivo screening model to predict compounds that alter blood glucose and/or insulin regulation. Journal of Pharmacological and Toxicological Methods 68:2, pages 190-196.
Crossref
Crossref
Hui Hua Chang, Mei Hung Chi, I Hui Lee, Hsin Chun Tsai, Po Wu Gean, Yen Kuang Yang, Ru-Band Lu & Po See Chen. (2013) The change of insulin levels after six weeks antidepressant use in drug-naïve major depressive patients. Journal of Affective Disorders 150:2, pages 295-299.
Crossref
Crossref
Eromona Whiskey & David Taylor. (2013) A review of the adverse effects and safety of noradrenergic antidepressants. Journal of Psychopharmacology 27:8, pages 732-739.
Crossref
Crossref
David E. Kemp, Marc De Hert, Zia Rahman, Paula Fyans, James M. Eudicone, Sabrina V. Marler, Ross A. Baker & Berit X. Carlson. (2013) Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine. Journal of Affective Disorders 148:1, pages 84-91.
Crossref
Crossref
F. Duval. (2013) Affections métaboliques et psychiatrie. EMC - Psychiatrie 10:2, pages 1-17.
Crossref
Crossref
Alessandra Alciati, Felice Gesuele, Giovanni Casazza & Diego Foschi. (2011) The Relationship between Childhood Parental Loss and Metabolic Syndrome in Obese Subjects. Stress and Health 29:1, pages 5-13.
Crossref
Crossref
Jae Moon YoonEun-Geol ChoHyun-Ki LeeSang Min Park. (2013) Antidepressant Use and Diabetes Mellitus Risk: A Meta-Analysis. Korean Journal of Family Medicine 34:4, pages 228.
Crossref
Crossref
Betina Biagetti. (2013) Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes. World Journal of Clinical Cases 1:5, pages 169.
Crossref
Crossref
Michael Deuschle. (2013) Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults. Current Opinion in Psychiatry 26:1, pages 60-65.
Crossref
Crossref
R Khanam, H Najfi, M Akhtar & D Vohora. (2012) Evaluation of venlafaxine on glucose homeostasis and oxidative stress in diabetic mice. Human & Experimental Toxicology 31:12, pages 1244-1250.
Crossref
Crossref
M. Deuschle & U. Schweiger. (2012) Depression und Diabetes mellitus Typ 2Depression and diabetes mellitus type 2. Der Nervenarzt 83:11, pages 1410-1422.
Crossref
Crossref
Sherif Sultan & Niamh Hynes. (2012) Cardiovascular disease: primary prevention, disease modulation and regenerative therapy. Vascular 20:5, pages 243-250.
Crossref
Crossref
Vladimir Skljarevski, Elijah P. Frakes, Doron Sagman, Sarah Lipsius, Alexandra N. Heinloth & Héctor J. Dueñas Tentori. (2012) Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain. Pain Research and Treatment 2012, pages 1-12.
Crossref
Crossref
Kerry Walker, Richard Toshner, Thekkepat C Sandeep, Marion Devers, Donald Bain & Nicholas Barwell. (2012) Linezolid-induced hypoglycaemia in a patient with type 1 diabetes. The British Journal of Diabetes & Vascular Disease 12:4, pages 186-188.
Crossref
Crossref
J.S. Ings, N. George, M.C.S. Peter, M.R. Servos & M.M. Vijayan. (2012) Venlafaxine and atenolol disrupt epinephrine-stimulated glucose production in rainbow trout hepatocytes. Aquatic Toxicology 106-107, pages 48-55.
Crossref
Crossref
A. Pan, Q. Sun, O. I. Okereke, K. M. Rexrode, R. R. Rubin, M. Lucas, W. C. Willett, J. E. Manson & F. B. Hu. (2011) Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia 55:1, pages 63-72.
Crossref
Crossref
Mika Kivimäki, G. David Batty, Markus Jokela, Klaus P. Ebmeier, Jussi Vahtera, Marianna Virtanen, Eric J. Brunner, Adam G. Tabak, Daniel R. Witte, Meena Kumari, Archana Singh-Manoux & Mark Hamer. (2011) Antidepressant Medication Use and Risk of Hyperglycemia and Diabetes Mellitus—A Noncausal Association?. Biological Psychiatry 70:10, pages 978-984.
Crossref
Crossref
Claudia Ress, Alexander Tschoner, Susanne Kaser & Christoph F. Ebenbichler. (2011) Psychopharmaka und DiabetesPsychotropic drugs and diabetes. Wiener Medizinische Wochenschrift 161:21-22, pages 531-542.
Crossref
Crossref
Jeanette M. Jerrell, Roger S. McIntyre & Avnish Tripathi. (2011) Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent‐onset bipolar disorder. Human Psychopharmacology: Clinical and Experimental 26:7, pages 451-459.
Crossref
Crossref
Chaker Ben Salem, Neila Fathallah, Houssem Hmouda & Kamel Bouraoui. (2011) Drug-Induced Hypoglycaemia. Drug Safety 34:1, pages 21-45.
Crossref
Crossref
H.-P. Kapfhammer. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
2511
2598
.
Mika KivimäkiMark HamerG. David BattyJohn R. GeddesAdam G. TabakJaana PenttiMarianna VirtanenJussi Vahtera. (2010) Antidepressant Medication Use, Weight Gain, and Risk of Type 2 Diabetes. Diabetes Care 33:12, pages 2611-2616.
Crossref
Crossref
Giesje Nefs, François Pouwer, Johan Denollet & Victor JM Pop. (2010) Psychological risk factors of micro- and macrovascular outcomes in primary care patients with type 2 diabetes: rationale and design of the DiaDDZoB Study. BMC Public Health 10:1.
Crossref
Crossref
Roger S. McIntyre, Ka Young Park, Candy W.Y. Law, Farah Sultan, Amanda Adams, Maria Teresa Lourenco, Aaron K.S. Lo, Joanna K. Soczynska, Hanna Woldeyohannes, Mohammad Alsuwaidan, Jinju Yoon & Sidney H. Kennedy. (2010) The Association between Conventional Antidepressants and the Metabolic Syndrome. CNS Drugs 24:9, pages 741-753.
Crossref
Crossref
Anna Ivanova, Danit Nitka & Norbert Schmitz. (2009) Epidemiology of antidepressant medication use in the Canadian diabetes population. Social Psychiatry and Psychiatric Epidemiology 45:9, pages 911-919.
Crossref
Crossref
A. K. B. Van Reedt Dortland, E. J. Giltay, T. Van Veen, F. G. Zitman & B. W. J. H. Penninx. (2009) Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatrica Scandinavica 122:1, pages 30-39.
Crossref
Crossref
Sue PearsonMike SchmidtGeorge PattonTerry DwyerLeigh BlizzardPetr OtahalAlison Venn. (2010) Depression and Insulin Resistance. Diabetes Care 33:5, pages 1128-1133.
Crossref
Crossref
Jeanette M. Jerrell. (2010) Adverse Events Associated With Psychotropic Treatment in African American Children and Adolescents. Journal of the National Medical Association 102:5, pages 375-383.
Crossref
Crossref
Jeanette M. Jerrell. (2010) Neuroendocrine‐Related Adverse Events Associated with Antidepressant Treatment in Children and Adolescents. CNS Neuroscience & Therapeutics 16:2, pages 83-90.
Crossref
Crossref
A.J. Scheen, B. Gillain & M. De Hert. (2010) Maladie cardiovasculaire et diabète chez les personnes atteintes d’une maladie mentale sévère. Médecine des Maladies Métaboliques 4:1, pages 93-102.
Crossref
Crossref
Yi-Chyan Chen, Wei-Win Lin, Yu-Jung Chen, Wei-Chung Mao & Yi-Jen Hung. (2010) Antidepressant Effects on Insulin Sensitivity and Proinflammatory Cytokines in the Depressed Males. Mediators of Inflammation 2010, pages 1-7.
Crossref
Crossref
A. Tschoner & C. Ebenbichler. (2009) Medikamente und DiabetesDrug-associated diabetes mellitus. Der Diabetologe 6:1, pages 37-43.
Crossref
Crossref
Mark P. Mattson. 2010. Hormesis. Hormesis
57
68
.
M. De Hert, J.M. Dekker, D. Wood, K.G. Kahl, R.I.G. Holt & H.-J. Möller. (2020) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry 24:6, pages 412-424.
Crossref
Crossref
Jeanette M. Jerrell, Janice Bacon, Judith T. Burgis & Seema Menon. (2009) Hyperprolactinemia-Related Adverse Events Associated with Antipsychotic Treatment in Children and Adolescents. Journal of Adolescent Health 45:1, pages 70-76.
Crossref
Crossref
Jeanette M. JerrellRoger S. McIntyre. (2009) Cardiovascular and Neurological Adverse Events Associated With Antidepressant Treatment in Children and Adolescents. Journal of Child Neurology 24:3, pages 297-304.
Crossref
Crossref
Marc De Hert, Jacqueline M. Dekker, David Wood, Kai G. Kahl & Hans-Jürgen Möller. (2009) Enfermedad cardiovascular y diabetes en personas con enfermedad mental grave. Revista de Psiquiatría y Salud Mental 2:1, pages 49-59.
Crossref
Crossref
M. J. Knol, M. I. Geerlings, D. E. Grobbee, A. C. G. Egberts & E. R. Heerdink. (2009) Antidepressant use before and after initiation of diabetes mellitus treatment. Diabetologia 52:3, pages 425-432.
Crossref
Crossref
Roger S. McIntyre, Natalie L. Rasgon, David E. Kemp, Ha T. Nguyen, Candy W. Y. Law, Valerie H. Taylor, Hanna O. Woldeyohannes, Mohammad T. Alsuwaidan, Joanna K. Soczynska, Byungsu Kim, Maria T. Lourenco, Linda S. Kahn & Benjamin I. Goldstein. (2009) Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap. Current Diabetes Reports 9:1, pages 51-59.
Crossref
Crossref
Marc De Hert, Jacqueline M. Dekker, David Wood, Kai G. Kahl & Hans-Jürgen Möller. (2009) Cardiovascular disease and diabetes in people with severe mental illness. Revista de Psiquiatría y Salud Mental (English Edition) 2:1, pages 49-59.
Crossref
Crossref
Patricia A. Colton & Gary Rodin. 2010. Diabetes in Women. Diabetes in Women
127
143
.
David S Harnett & Ronald Pies. 2008. Mood Disorders in Later Life. Mood Disorders in Later Life
179
196
.
Kathrin Overbeck, Daniel Genné, Alain Golay & Francesco Negro. (2008) Pioglitazone in chronic hepatitis C not responding to pegylated interferon-α and ribavirin. Journal of Hepatology 49:2, pages 295-298.
Crossref
Crossref
An Pan, Xingwang Ye, Oscar H. Franco, Huaixing Li, Zhijie Yu, Shurong Zou, Zheng Zhang, Shufang Jiao & Xu Lin. (2008) Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: Findings from the Nutrition and Health of Aging Population in China Study. Journal of Affective Disorders 109:1-2, pages 75-82.
Crossref
Crossref
M. Flechtner-Mors, C.P. Jenkinson, A. Alt, G. Adler & H.H. Ditschuneit. (2008) Metabolism in adipose tissue in response to citalopram and trimipramine treatment – An in situ microdialysis study. Journal of Psychiatric Research 42:7, pages 578-586.
Crossref
Crossref
M. J. Knol, H. J. Derijks, M. I. Geerlings, E. R. Heerdink, P. C. Souverein, K. J. Gorter, D. E. Grobbee & A. C. G. Egberts. (2008) Influence of antidepressants on glycaemic control in patients with diabetes mellitus. Pharmacoepidemiology and Drug Safety 17:6, pages 577-586.
Crossref
Crossref
S. Saddichha, N. Manjunatha, S. Ameen & S. Akhtar. (2008) Diabetes and schizophrenia – effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia. Acta Psychiatrica Scandinavica 117:5, pages 342-347.
Crossref
Crossref
Hieronymus J. Derijks, Ronald H. B. Meyboom, Eibert R. Heerdink, Fred H. P. De Koning, Rob Janknegt, Marie Lindquist & Antoine C. G. Egberts. (2008) The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. European Journal of Clinical Pharmacology 64:5, pages 531-538.
Crossref
Crossref
Ulrich Schweiger, Wiebke Greggersen, Sebastian Rudolf, Matthias Pusch, Tilmann Menzel, Sebastian Winn, Jan Hassfurth, Eva Fassbinder, Kai G. Kahl, Kerstin M. Oltmanns, Fritz Hohagen & Achim Peters. (2008) Disturbed Glucose Disposal in Patients With Major Depression; Application of the Glucose Clamp Technique. Psychosomatic Medicine 70:2, pages 170-176.
Crossref
Crossref
Andrea Fagiolini, K N Roy Chengappa, Isabella Soreca & Jane Chang. (2008) Bipolar Disorder and the Metabolic Syndrome. CNS Drugs 22:8, pages 655-669.
Crossref
Crossref
Scott D. Mendelson. 2008. Metabolic Syndrome and Psychiatric Illness. Metabolic Syndrome and Psychiatric Illness
73
91
.
H. -P. Kapfhammer. 2008. Psychiatrie und Psychotherapie. Psychiatrie und Psychotherapie
1501
1566
.
Miranda A. L. van Tilburg, Anastasia Georgiades & Richard S. Surwit. 2008. Type 2 Diabetes Mellitus. Type 2 Diabetes Mellitus
403
412
.
Yi-Chyan Chen, Yu-Chih Shen, Yi-Jen Hung, Chou Chao-Ha, Chin-Bin Yeh & Cheng-Hwang Perng. (2007) Comparisons of glucose–insulin homeostasis following maprotiline and fluoxetine treatment in depressed males. Journal of Affective Disorders 103:1-3, pages 257-261.
Crossref
Crossref
John H.J.M. Meertens, Wilma E. Monteban-Kooistra, Jack J.M. Ligtenberg, Jaap E. Tulleken & Jan G. Zijlstra. (2007) Severe Hypoglycemia Following Venlafaxine Intoxication. Journal of Clinical Psychopharmacology 27:4, pages 414-415.
Crossref
Crossref
Eva M. Vivian. (2007) <b>The Pharmacist's Role in Maintaining Adherence to Insulin Therapy in Type 2 Diabetes Mellitus Clinical Review</b>. The Consultant Pharmacist 22:4, pages 320-332.
Crossref
Crossref
Marcelo Papelbaum, José Carlos Appolinário, Rodrigo de Oliveira Moreira, Mônica Duchesne, Rosane Kupfer & Walmir Ferreira Coutinho. (2007) Distribuição de transtornos alimentares em indivíduos com diabetes melito do tipo 1 e do tipo 2: descrição de dois casos. Revista de Psiquiatria do Rio Grande do Sul 29:1, pages 93-96.
Crossref
Crossref
Dan Ziegler, Yili L. Pritchett, Fujun Wang, Durisala Desaiah, Michael J. Robinson, Jerry A. Hall & Amy S. Chappell. (2007) Impact of Disease Characteristics on the Efficacy of Duloxetine in Diabetic Peripheral Neuropathic Pain. Diabetes Care 30:3, pages 664-669.
Crossref
Crossref
Mutlu Vural, Ömer Satiroglu, Berfu Akbas, Isin Göksel & Öcal Karabay. (2007) Association between Depression and Anxiety Symptoms and Major Atherosclerosis Risk Factors in Patients with Chest Pain. The Tohoku Journal of Experimental Medicine 212:2, pages 169-175.
Crossref
Crossref
C. Fibbe & P. Layer. (2006) Gastrointestinale Nebenwirkungen durch PsychopharmakaGastrointestinal side-effects of antipsychotic agents. Der Gastroenterologe 1:3, pages 197-208.
Crossref
Crossref
Wayne S Fenton & Ellen S Stover. (2006) Mood disorders: cardiovascular and diabetes comorbidity. Current Opinion in Psychiatry 19:4, pages 421-427.
Crossref
Crossref